We are hiring an Assistant Professor of Chemistry and a Lecturer to join our faculty! Both searches are now open and we are accepting applications through October 15th via the Interfolio application portal. Applicants are encouraged to submit all materials by September 15th to ensure full consideration.
Successful appointees will join the department during an exciting period of growth and help build our teacher-scholar model of excellence in both teaching and research.
We encourage interested applicants to view the full job descriptions:
The search committees are chaired by Dr. Brian Dyer (Assistant Professor) and Dr. Vincent Conticello (Lecturer). Applicants with questions are encouraged to contact chemsearch [at] emory [dot] edu as a first point of contact for a swift response.
Human augmentation. Sounds like the theme of a highly-rated, futuristic SciFi movie, right? In the realm of chemistry, however, the idea of enhancing human capability often guides some of the most impactful research. For example, research in the Wuest lab is focused on the development of new antibiotics inspired by nature. From identifying and synthesizing to characterizing and optimizing, researchers in the Wuest lab hope to improve upon natural products with the ultimate goal of commercialization. Because of their ability to alter the human microbiome, the therapeutic use of these antibiotics lends itself to improving the human function.
These research efforts recently earned Dr. Wuest the distinction of being named a Leshner Leadership Institute Public Engagement Fellow. The Leshner Fellow program was developed by the American Association for the Advancement of Science (AAAS) to train scientists to be more active in public engagement and government policy discussions. Each year, the program selects a theme that they deem to be of importance in the realm of public engagement. The theme of the year was Human Augmentation, which followed such past themes as Infectious Diseases, Food and Water Security, and Climate Change.
As a Leshner Fellow, Dr. Wuest was given the opportunity to participate in a week-long orientation designed to facilitate issue-specific scientific communication and to encourage attendees to serve as leaders in public engagement. Instructional modules covered topics from video production and graphics to social media. “We met with a panel of journalists to learn how to engage with them about research stories we are working on,” says Dr. Wuest. “We received training in how to engage policy makers on Capitol Hill and create one page ‘drop sheets’. We also were instructed on how to give televised interviews and participated in one recording for the Leshner video.” In addition, the meeting provided a stage for attendees to initiate collaborations with other leaders in the field.
“The highlight of the week was our visit to Capitol Hill,” says Dr. Wuest. He met with staff members of the Senate Commerce Committee, The House Committee on Science and Technology, and with the office of Representative Bill Foster (D-IL), with whom he was able to communicate his passion for graduate student training and the need for diversity and inclusion in the sciences (the current focus of two bills in Congress). “I focused my pitch on the specific training of graduate students through an increase in federal funding to fellowships and training grants as opposed to directly to the PI, which is the primary mode of funding graduate students currently,” he explains. This concept is also the topic of an op-ed that he is co-writing with 4 other fellows.
At the end of the orientation week, Dr. Wuest walked away with answers to such questions as “How do you engage writers and editors?”, “What is the best approach to impacting policy?”, and “What is the best way to make institutional change within your organization?”. Moreover, each fellow was guided towards developing and implementing two engagement plans for the upcoming year. For Dr. Wuest, the first plan is centered around educating the public on the issues of antimicrobial resistance and the development of new antibiotics. “My plan involves writing a number of op-eds to educate the public as well as organizing public forums around the topic,” he says. For his second plan, Dr. Wuest is focusing on the further development of a culture of innovation and entrepreneurship at Emory University. This aim, he says, is derived from his relationship with the Georgia Research Alliance. In collaboration with Emory, this organization awarded him a Distinguished Investigator endowed chair when he moved here in 2017.
“The experience has made a significant impact on how I think about communicating my science and the reach I would like my findings to have,” says Dr. Wuest. He is already capitalizing on some of the training he received during orientation, having recently engaged with a number of journalists to help share his message. He had an interview with NPR regarding a recent publication that is set to air sometime this month, and he contacted Senator Isakson (R-GA) who currently has proposed a bipartisan bill, the DISARM Bill, which seeks to address the issue of antibiotic development in the private sector.
Beyond just sharing his interest in antibiotics and research, Dr. Wuest also hopes to inspire others to take a similar approach to communicating their own science. “I would encourage not only faculty but students as well to think more broadly about public engagement in all areas, whether it be social media, SciComm, writing op-eds, emailing local representatives, etc.,” he says. “Without public support, a lot of the science we do will not be possible.”
The Emory News Center recently published an article outlining a series of initiatives through which Emory University hopes to foster scholarly and research eminence. As part of its mission, titled “One Emory: Engaged for Impact”, Emory aims to inspire “Innovation through Scholarship and Creative Expression”. To achieve this goal, a Task Force on the Future of Basic Science Research was organized to identify how to maximize the success and impact of our research efforts.
This task force was co-chaired by Guida Silvestri and the Department of Chemistry’s own Dr. Huw Davies. Two priority research initiatives were decided upon as a result of this effort: “Biological Discovery through Chemical Innovation” and “From Molecular Pathogenesis to Global Pandemics”. Dr. Davies, along with Dr. Haian Fu, leads the “Biological Discovery through Chemical Innovation” initiative with the aim of accelerating the development of the next generation of research tools, effective and safe drugs, and diagnostic agents.
“The idea is to enhance molecular science at Emory broadly,” says Davies. “The focus is not just on the potential for developing drugs, but on achieving more impactful basic science by deepening knowledge of biology and novel chemistry.”
Young Emory scientists wanted a taste of what biotech business careers might be like. So they visited the world’s largest poultry industry conference, and got advice from officials at the Food and Drug Administration – all within a couple months.
“I learned a ton about chickens – more than I thought possible. I’ve been explaining it all to my friends,” says Henry Zecca, a graduate student in the Department of Chemistry.
Zecca’s experience and others emerged at a “Gala” Tuesday evening showcasing the Emory Biotech Consulting Club, which aimed to pair student advisory teams with fledgling startup companies emerging from university research.
Dr. Jen Heemstra has teamed up with C&EN for the new advice column, “Office Hours.” The monthly column will “engage the STEM community in dialogue on important issues–including prioritizing mental health, finding motivations, and coping with setbacks and failures.” A key feature will be questions or topic ideas from readers that will kick off each column, helping “Office Hours” become a catalyst for broader conversation.
Jen’s is also featured in the latest episode of the C&EN podcast, Stereo Chemistry. The podcast team spent several days in the lab getting to know Jen and her students and “learning how and why she’s helping create the next generation of chemistry’s thought leaders.” You can listen here.
Congratulations to Dr. Christine Dunham and colleagues on their recent publication in Proceedings of the National Academy of Sciences. This manuscript has won the journal’s Cozzarelli Prize, which recognizes one outstanding contribution each year to each of the six disciplines of the National Academy of Sciences and celebrates “scientific excellence and originality”.
The manuscript entitled “Mechanism of tRNA-mediated +1 ribosomal frameshifting” discusses ribosomal frameshifting, a perturbation of the protein assembly process. With an enhanced understanding of this process, we can begin to understand more about how proteins are synthesized as well as how some antibiotics can hijack this process and re-engineer it for new applications.
Congratulations to Dr. Simon Blakey for being elected to the Advisory Committee of the International Society of Heterocyclic Chemistry (ISHC)! The ISHC was established in 1968 to promote heterocyclic chemistry by sponsoring the ISHC-Congress, to honor individuals who have made outstanding contributions to the field, and to aid in the publication of “Progress in Heterocyclic Chemistry” (PHC). With this appointment, Dr. Blakey will serve as one of two North American representatives on the committee of nine members.
Research in the Blakey lab centers around probing fundamental questions of chemical reactivity, catalysis, and synthetic strategy with an emphasis on selective C-H functionalization. If you are interested in learning more about the Blakey lab, check out their new website [here]!
The Quantum Information Science program seeks to lay the foundation for future innovation in the realm of computing and information processing. The awards, made in conjunction with the White House Summit on Advancing American Leadership in Quantum Information Science, are led by scientists at 28 higher learning institutes and 9 DOE national laboratories. Research funded by the awards will span a range of topics from the new generation of quantum computers to using quantum computing for understanding cosmic phenomena.
The abstract for Dr. Evangelista’s “Quantum Chemistry for Quantum Computers” appears below:
“Over the past fifty years, quantum chemistry has had a transformative impact on chemistry and materials science by enabling the computational prediction of properties and reactivity of molecules and materials. Two factors have made this success possible: the development of efficient theories of electronic structure and the steady growth of computing power. Nevertheless, quantum chemistry methods are currently unable to tackle strongly correlated molecules and materials, owing to the exponential complexity of the fundamental physics of these systems. Quantum computers manipulate information using quantum mechanical principles and offer a solution to this problem. With the rapid development of quantum computing hardware and algorithms, there is a realistic expectation that quantum computers will outperform their classical counterparts within the next decade. However, the first generation of quantum computers is unlikely to have a transformative impact on chemistry and materials science unless their power is leveraged by combining them with new algorithms specifically designed to take advantage of quantum hardware. The objective of this research is to create the next generation of quantum chemistry methods for strongly correlated molecules and solids that will run on the first generation of quantum computers. This research will also develop standard benchmarks for testing the accuracy and computing power of new quantum hardware and will validate prototypes of quantum computers in collaborations with industry partners. More generally, this project paves the way to applications of quantum computers to study challenging strongly correlated systems critical to the mission of the DOE such as transition metal catalysts, high-temperature superconductors, and novel materials that are beyond the realm of classical simulation.”
Congratulations, Dr. Evangelista!
Check out the video to learn more about the amazing research happening in the Evangelista lab!
Congratulations to Dr. Dennis Liotta for receiving an honorary Doctor of Science degree from the University of Ottawa. Honorary doctorate degrees acknowledge the value of the abilities and experiences of the recipient and are awarded for significant contributions made by the recipient to the University of Ottawa, their profession, or society. Upon receiving the honorary degree, Dr. Dennis Liotta delivered a speech to the graduating class of the University.
“We can’t afford to sit and wait for others to change the world — we have to do it ourselves. The good news is that we all have the capacity to make the world a better place. All that is required is that we be proactive and persistent on an issue or cause that we’re passionate about. So, this is my challenge to all of you here today. Examine your own lives, identify a problem compatible with your skills and pursue it. If it’s something you’re passionate about and you’re willing to persevere, I guarantee you that you’ll find a way of doing it well. Remember, however, that this is marathon, not a sprint. So, don’t ever lose sight of your goals and your dreams.”